Genelux (GNLX) Other financing activities (2023 - 2026)
Genelux (GNLX) posted quarterly Other financing activities of $13000.0 for Q1 2026, down 7.14% year-over-year from $14000.0 in Q1 2025, and down 7.14% quarter-over-quarter from $14000.0 in Q1 2025.
Genelux (GNLX) Other financing activities (2023 - 2026) Analysis & Trends
Genelux's Other financing activities history runs 4 years deep, the most recent figure standing at $13000.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 7.14% year-over-year to $13000.0; the TTM figure through Mar 2026 stood at $13000.0 (down 7.14% YoY), while the FY2025 annual figure was $14000.0, down 97.97% from the prior year.
- Other financing activities for Q1 2026 stood at $13000.0, down from $14000.0 in the prior quarter.
- The five-year high for Other financing activities was $14.5 million in Q1 2023, with the low at -$1.3 million in Q4 2023.
- The 4-year median for Other financing activities is $13500.0 (2025), against an average of $2.3 million.
- The sharpest annual moves came in 2025 and 2026: Other financing activities tumbled 97.97% in 2025, then fell 7.14% in 2026.
- Genelux's Other financing activities stood at -$1.3 million in 2023, then soared by 154.3% to $688000.0 in 2024, then sank by 97.97% to $14000.0 in 2025, then retreated by 7.14% to $13000.0 in 2026.
- Business Quant data shows GNLX's Other financing activities at $13000.0 in Q1 2026, $14000.0 in Q1 2025, and $688000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Genelux | 119.87 Mn | 119.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2024 | 688,000.00 |
| Mar 31, 2024 | 688,000.00 |
| Dec 31, 2023 | -1.27 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | 1,321.00 |
| Sep 30, 2023 | 1,321.00 |
| Mar 31, 2023 | 14.50 Mn |
| Mar 31, 2023 | 14.50 Mn |